UPDF AI

Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the D:A:D Study

C. Hatleberg,DR Lene Ryom,11 Authors,Caroline Sabin

2018 · DOI: 10.1111/hiv.12639
HIV Medicine · 44 Citations

TLDR

The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) cohort investigated whether exposure to antiretroviral drugs poses additional risk of hypertension in HIV‐positive individuals.

Abstract

Previous studies have suggested that hypertension in HIV‐positive individuals is associated primarily with traditional risk factors such as older age, diabetes and dyslipidaemia. However, controversy remains as to whether exposure to antiretroviral (ARV) drugs poses additional risk, and we investigated this question in the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) cohort.